TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07749170: FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions

Sponsor: Penumbra Inc. · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 250 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$12,416,000

Rescue Site Savings

+$8,186,800

Unlock Full NCT07749170 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07749170 Rescue Dossier →